|
⚲
|
| Keyboard |
| Christopher Richard | |
|---|---|
| Firm | |
| Address | 1435 NW Northrup Street Portland, OR 97209 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Staffupapp Corp | 021-512275 | Executive Officer | of 2.0 M |
||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexaria Corp LEXX
common shares
|
2025-07-29 | Buy | 15,000 | $0.91 | 13,650 |
|
Lexaria Corp LEXX
Stock Options · derivative
|
2025-05-15 | Grant | 150,000 | $0.00 | |
|
Lexaria Corp LEXX
common shares
|
2024-12-03 | Buy | 27,172 | $2.47 | 67,115 |
|
Lexaria Corp LEXX
common shares
|
2024-12-02 | Buy | 22,828 | $2.24 | 51,135 |
|
Invivo Therapeutics Holdings Corp NVIV
Stock Option (right to buy) · derivative
|
2022-11-17 | Grant | 20,800 | $0.00 | |
|
Invivo Therapeutics Holdings Corp NVIV
Stock Option (right to buy) · derivative
|
2021-03-18 | Grant | 75,000 | $0.00 | |
|
Invivo Therapeutics Holdings Corp NVIV
Common Stock
|
2020-03-10 | Buy | 3,636 | ||
|
Invivo Therapeutics Holdings Corp NVIV
Warrant (right to buy) · derivative
|
2020-03-10 | Buy | 3,636 | ||
|
Invivo Therapeutics Holdings Corp NVIV
Common Stock
|
2019-09-25 | Grant | 47,500 | $0.00 | |
|
Invivo Therapeutics Holdings Corp NVIV
Nonstatutory Stock Option (right to buy) · derivative
|
2019-01-14 | Grant | 90,000 | $0.00 | |
|
ICAD Inc ICAD
Convertible Debenture · derivative
|
2018-12-21 | Grant | 5,000 | $4.00 | 20,000 |
|
ICAD Inc icad
Common Stock
|
2018-12-05 | Tax withheld | 4,909 | $4.08 | 20,029 |
|
ICAD Inc icad
Commom Stock
|
2018-03-30 | Grant | 58,333 | $3.08 | 179,666 |
|
ICAD Inc icad
Common Stock
|
2018-03-30 | Tax withheld | 6,735 | $3.08 | 20,744 |
|
ICAD Inc icad
Common Stock
|
2018-03-22 | Grant | 25,000 | $0.00 | |
|
ICAD Inc iCAD
Common Stock
|
2017-12-05 | Tax withheld | 5,409 | $3.52 | 19,040 |
|
ICAD Inc ICAD
Common Stock
|
2017-05-04 | Grant | 1,574 | $0.00 | |
|
ICAD Inc ICAD
Common Stock
|
2016-12-05 | Grant | 50,000 | $0.00 | |
|
DUSA Pharmaceuticals Inc DUSA
Common Stock
|
2012-12-20 | Tender | 66,862 | $8.00 | 534,896 |
|
DUSA Pharmaceuticals Inc DUSA
Common Stock
|
2012-12-20 | Tender | 209,150 | $8.00 | 1,673,200 |
| showing 20 of 34 most recent transactions | |||||